Cao Xie Selected Research

Vascular Endothelial Growth Factor Receptors (VEGF Receptors)

1/2021

A pentapeptide enabled AL3810 liposome-based glioma-targeted therapy with immune opsonic effect attenuated.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cao Xie Research Topics

Disease

33	Neoplasms (Cancer) 03/2023 - 05/2009
26	Glioma (Gliomas) 04/2024 - 12/2013
14	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 04/2010
11	Brain Neoplasms (Brain Tumor) 04/2024 - 07/2011
3	Breast Neoplasms (Breast Cancer) 03/2023 - 01/2022
3	Fibrosis (Cirrhosis) 12/2021 - 09/2011
3	Liver Cirrhosis (Hepatic Cirrhosis) 12/2021 - 07/2010
2	Triple Negative Breast Neoplasms 01/2023 - 01/2022
2	Neoplasm Metastasis (Metastasis) 01/2023 - 10/2017
2	Thrombosis (Thrombus) 04/2022 - 12/2020
2	Adenocarcinoma 10/2020 - 08/2015
2	Hemolysis 07/2019 - 04/2016
1	COVID-19 11/2023
1	Communicable Diseases (Infectious Diseases) 11/2023
1	Hemorrhage 04/2022
1	Embolism (Embolus) 04/2022
1	Circulating Neoplastic Cells 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021
1	Atherosclerosis 11/2021
1	Central Nervous System Diseases (CNS Diseases) 11/2021
1	Brain Diseases (Brain Disorder) 11/2021
1	Residual Neoplasm 10/2021
1	Hypothermia 01/2021

Drug/Important Bio-Agent (IBA)

26	Peptides (Polypeptides)IBA 04/2024 - 01/2012
17	LigandsIBA 03/2023 - 01/2013
16	MicellesIBA 01/2020 - 05/2009
15	Liposomes (Liposome)IBA 01/2022 - 01/2012
10	Proteins (Proteins, Gene)FDA Link 04/2024 - 09/2005
10	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2024 - 01/2013
10	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 04/2010
7	Neuropilin-1IBA 09/2018 - 10/2013
5	Endoplasmic Reticulum Chaperone BiPIBA 04/2024 - 10/2017
5	IntegrinsIBA 01/2021 - 09/2011
5	monomethoxypolyethylene glycol (MPEG)IBA 06/2015 - 05/2009
4	polypeptide CIBA 01/2021 - 04/2010
3	Temozolomide (Temodar)FDA LinkGeneric 10/2021 - 11/2015
3	monomethoxypolyethyleneglycol- polylactide block copolymerIBA 01/2020 - 04/2010
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018 - 06/2016
3	cyclic arginine-glycine-aspartic acid peptideIBA 09/2017 - 04/2010
3	PolyethyleneimineIBA 08/2015 - 12/2013
3	poly(ethylene glycol)-co-poly(ethyleneimine)IBA 08/2015 - 12/2013
3	Ethylene Glycol (Monoethylene Glycol)IBA 06/2015 - 04/2010
3	1,2-distearoylphosphatidylethanolamine (DSPE)IBA 06/2015 - 05/2009
3	polyethylene glycol- distearoylphosphatidylethanolamineIBA 10/2014 - 05/2009
2	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 03/2023
2	Dopamine Receptors (Dopamine Receptor)IBA 04/2024 - 09/2017
2	Biotin (Vitamin H)FDA Link 03/2024 - 04/2015
2	cabazitaxel FDA Link 01/2022 - 01/2022
2	Therapeutic UsesIBA 01/2022 - 10/2013
2	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2021 - 09/2011
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2021 - 04/2012
2	Gemcitabine FDA Link 12/2021 - 09/2018
2	GadoliniumIBA 12/2021 - 04/2015
2	LipidsIBA 11/2021 - 04/2016
2	Small Interfering RNA (siRNA)IBA 10/2021 - 11/2019
2	AntibodiesIBA 01/2021 - 10/2020
2	phenolic acidIBA 10/2020 - 09/2017
2	PolymersIBA 10/2020 - 05/2009
2	GlycopeptidesIBA 07/2019 - 01/2018
2	Melitten (Melittin)IBA 07/2019 - 04/2016
2	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 10/2018 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 07/2017 - 01/2015
2	Tumor Suppressor Protein p53IBA 11/2015 - 04/2012
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2014 - 05/2009
2	Thioacetamide (Thioacetamid)IBA 04/2012 - 09/2011
2	Antineoplastic Agents (Antineoplastics)IBA 01/2012 - 05/2009
1	AvidinIBA 03/2024
1	Docetaxel (Taxotere)FDA Link 03/2024
1	VaccinesIBA 11/2023
1	Molecular Probes (Molecular Probe)IBA 03/2023
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 03/2023
1	Arginine (L-Arginine)FDA Link 04/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 04/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2022
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 04/2022
1	apolipoprotein A-IV (apolipoprotein AIV)IBA 01/2022
1	Protein CoronaIBA 01/2022
1	Membrane LipidsIBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	Transferrin (beta 2 Transferrin)IBA 01/2022
1	Cyclic PeptidesIBA 12/2021
1	MitogensIBA 12/2021
1	Platelet-Derived Growth FactorIBA 12/2021
1	trimethyloxamine (trimethylamine N-oxide)IBA 11/2021
1	HydrogelsIBA 10/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2021
1	lumbrokinaseIBA 12/2020
1	Immune Checkpoint InhibitorsIBA 10/2020
1	2-aminoimidazoleIBA 10/2020

Therapy/Procedure

20	Therapeutics 01/2023 - 05/2010
7	Drug Therapy (Chemotherapy) 04/2024 - 06/2015
5	Intravenous Administration 10/2020 - 04/2010